Given the importance of angiogenesis in a variety of physiological and pathological processes including tumor growth, the HDAC10-PTPN22-ERK1/2 signaling axis may provide a useful target for the development of novel therapeutic strategies to control diseases associated with abnormal angiogenesis. This evidence concerns the gene PTPN22 and neoplasm.